Carie Detectors segmentation by type categorises devices according to the underlying detection principle and form factor, each influencing adoption curves and revenue composition. Laser‑fluorescence units, which emit a 655 nm beam and analyse emitted fluorescence, dominate the premium tier and are estimated to generate roughly 40 % of total sales, driven by high diagnostic accuracy and strong clinical validation. Electrical‑conductance systems, operating on low‑frequency impedance measurements, occupy the mid‑range market with an approximate 25 % share; their lower capital cost makes them attractive for high‑volume general practices. Optical‑transillumination devices, including near‑infrared (NIR) and visible‑light transillumination, contribute about 20 % of revenue, reflecting growing interest in non‑invasive imaging that can be integrated into digital workflow. Acoustic‑emission detectors, which capture ultrasonic signals from demineralization sites, remain a niche segment at roughly 5 % share, limited by sensitivity constraints. Finally, hybrid platforms that combine two or more modalities account for the remaining 10 % and are positioned for future growth as clinical guidelines endorse multimodal assessment. The relative weighting of each type directly determines component‑level demand, service contracts, and R&D allocation within the Carie Detectors market.
